Digital Pathology Market by Application (Disease Diagnosis, Drug Discovery, Teleconsultation), Product (Scanner, Software, Communication System), Type (Human, Veterinary), End User (Pharmaceutical & Biotechnology Companies) - Global Forecast to 2022
[154 Pages Report] The global digital pathology market is projected to be valued at $383.9 Million in 2016 and is expected to grow at a CAGR of 12.3% from 2017 to reach to $756.1 Million by 2022. Growth in the overall digital pathology market is mainly driven by factors such as the growing applications of digital pathology in drug development and companion diagnostics, ease of consultation, increasing adoption of digital pathology to enhance lab efficiency, rising prevalence of cancer, and increasing initiatives by governments and industry players. Base year considered for the report is 2016 and the forecast period is 20172022.
Selected Market Dynamics in Digital Pathology Market
Rising prevalence of cancer
The global incidence of cancer is increasing. According to the WHO, cancer is the second-leading cause of death globally and was responsible for 8.8 million deaths in 2015. The number of new cancer cases is expected to increase by about 70% over the next two decades. The American Cancer Society reported that cancer accounts for 1 in every 7 deaths worldwide. According to the same report, cancer is the second-most common cause of death after heart disease in the US; approximately 1,688,780 new cancer patients are expected to be diagnosed in 2017 in the US.
With the increasing prevalence of cancer, the need for faster and more accurate methods of subtyping diseases is on the rise. Digital pathology systems offer an accurate diagnosis and easy exchange of data among pathologists, thus improving diagnostic quality. The increasing prevalence of cancer worldwide is thus likely to drive the market for digital pathology.
High cost of digital pathology systems
A typical digital pathology system, which includes a slide scanner, an image server, and software, costs around USD 150,000 to USD 200,000. Although large hospitals with significant capital budgets can afford these systems, pathologists and academic institutes with limited budgets or IT support often cannot afford them. This limits the uptake of these systems.
Objectives of the Study:
- To define and measure the global market on the basis of product, type, end users, application, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
- To identify the key micromarkets and their drivers within the global market
- To forecast the size of the digital pathology market segments with respect to four regions, namely, North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW)
- To identify the market trends and opportunities for stakeholders in the market and provide details of the competitive landscape for major digital pathology market players
- To profile the key market players and comprehensively analyze their market shares and core competencies
- To track and analyze competitive developments such as partnerships, agreements, and collaborations; expansions; acquisitions; and product launches
Research Methodology:
Top-down and bottom-up approaches were used to validate the size of the global market and estimate the size of other dependent submarkets. Various secondary sources such as associations like the U.S. Food and Drug Administration, Digital Pathology Association College of American Pathologists, American Society for Clinical Pathology, European Society of Pathology, Pathological Society of Great Britain and Ireland, International Academy of Pathology, International Association of Chinese Pathologists Centers for Medicare and Medicaid Services, directories, industry journals, databases, and annual reports of the companies have been used to identify and collect information useful for the study of this digital pathology market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market. The breakdown of profiles of primaries is shown in the figure below:
To know about the assumptions considered for the study, download the pdf brochure
The prominent players in the global digital pathology market are Leica Biosystems (Germany), Ventana Medical Systems (US), Hamamatsu Photonics (Japan), 3DHISTECH (Hungary), and Philips (Netherlands).
Target Audience:
- Digital pathology equipment manufacturers
- Suppliers and distributors of digital pathology equipment
- Medical research institutes
- Research institutes
- Vendors/service providers
Scope of the Report:
The research report categorizes the overall digital pathology market into the following segments and subsegments:
By Product
- Scanners
- Software
- Communication Systems
- Storage Systems
By Type
- Human Pathology
- Veterinary Pathology
By End User
- Pharmaceutical & Biotechnology Companies
- Hospital and Reference Laboratories
- Academic & Research Institutes
By Application
- Teleconsultation
- Disease Diagnosis
- Drug Discovery
- Training & Education
By Region
- North America
- US
- Canada
- Europe
- UK
- Germany
- Sweden
- Denmark
- Rest of Europe (RoE)
- APAC
- China
- Japan
- India
- RoAPAC
- Rest of the World
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the companys specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (Up to 5)
On the basis of product, the digital pathology market is categorized into scanners, software, communication systems, and storage systems. The software segment is projected to witness the highest growth rate in the forecast period, due to the availability of user-friendly, analytical, and advanced functions for pathology diagnosis.
On the basis of type, the digital pathology market is segmented into human and veterinary pathology. The human pathology segment is expected to account for the largest share of the market in 2017. The increasing number of cancer research activities and growing collaborations between academic research institutes, universities, and pathology laboratories are driving the increased uptake of digital systems in human pathology.
On the basis of application, the digital pathology market is segmented into disease diagnosis, teleconsultation, drug discovery, and training & education. The teleconsultation segment is estimated to account for the largest share of the global market in 2017. Shortage of pathologists in developing countries and increasing need for quality and fast diagnosis have enhanced the utilization of teleconsultation applications across the globe.
On the basis of end user, the global digital pathology market has been segmented into pharmaceutical and biotechnology companies, hospitals and reference laboratories, and academic & research institutes. The pharmaceutical and biotechnology companies segment is estimated to account for the largest share of the global market in 2017. Key factors driving the growth of this segment is the usage digital pathology for biobanking, biopharmaceutical studies, and molecular assays.
In 2017, North America is expected to account for the largest share of the digital pathology market, followed by Europe. The large share of the North American region can be attributed to factors such as increasing initiatives by industry players and governments in diagnostics and the rising prevalence of chronic diseases.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Table of Contents
1 Introduction (Page No. - 13)
1.1 Objectives of the Study
1.2 Market Definition
1.3 digital pathology Market Scope
1.3.1 Markets Covred
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. - 16)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Research
2.1.2.1 Breakdown of Primaries
2.1.2.2 Key Data From Primary Sources
2.2 Market Size Estimation Methodology
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Data Validation and Triangulation
2.4 Assumptions for the Study
3 Executive Summary (Page No. - 25)
4 Premium Insights (Page No. - 30)
4.1 Digital Pathology Market: Overview
4.2 European Market Share, By Application and Country (2017)
4.3 Global Market, By Type vs Country 2017 vs 2022
4.4 Geographic Snapshot of the Global Market
5 Market Overview (Page No. - 33)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Adoption of Digital Pathology to Enhance Lab Efficiency
5.2.1.2 Rising Prevalence of Cancer
5.2.1.3 Growing Applications of Digital Pathology in Drug Development and Companion Diagnostics
5.2.1.4 Ease of Consultation Enabled By Digital Pathology
5.2.1.5 Increasing Initiatives By Governments and Industry Players
5.2.2 Restraints
5.2.2.1 High Cost of Digital Pathology Systems
5.2.3 Opportunities
5.2.3.1 Overcoming the Shortage of Pathologists Through Digital Pathology
5.2.3.2 Introduction of Affordable Scanners for Private Pathology Practices
5.2.3.3 Personalized Medicine
5.2.3.4 Integration of Laboratory Information Systems (LIS) and Digital Pathology Systems
5.2.4 Challenges
5.2.4.1 Lack of Standard Guidelines
5.3 Regulatory Implications
5.3.1 Health Insurance Portability and Accountability Act (HIPAA)
5.3.2 Clinical Laboratory Improvement Amendments (CLIA)
6 Digital Pathology Market, By Product (Page No. - 41)
6.1 Introduction
6.2 Scanners
6.3 Software
6.4 Communication Systems
6.5 Storage Systems
7 Digital Pathology Market, By Type (Page No. - 48)
7.1 Introduction
7.2 Human Pathology
7.3 Veterinary Pathology
8 Market, By Application (Page No. - 52)
8.1 Introduction
8.2 Teleconsultation
8.3 Disease Diagnosis
8.4 Drug Discovery
8.5 Training and Education
9 Market, By End User (Page No. - 58)
9.1 Introduction
9.2 Pharmaceutical & Biotechnology Companies
9.3 Hospitals and Reference Laboratories
9.4 Academic & Research Institutes
10 Global Market, By Region (Page No. - 63)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.1.1 Favorable Reimbursement Scenario for Digital Pathology in the US
10.2.1.2 Rising Cancer Prevalence in the US
10.2.1.3 De Novo Application By the FDA
10.2.1.4 Conferences and Meetings in the US
10.2.2 Canada
10.2.2.1 Growing Need for Quality Cancer Diagnosis in Canada
10.2.2.2 Implementation of Favorable Initiatives By Canadian Authorities
10.3 Europe
10.3.1 UK
10.3.1.1 Initiatives Adopted By Nhs England Promoting the Adoption of Digital Pathology in the UK
10.3.1.2 Technological Developments in the UK Market
10.3.1.3 Organization of Digital Pathology-Related Conferences in the UK
10.3.2 Germany
10.3.2.1 Organization of Digital Pathology-Related Conferences in Germany
10.3.3 Sweden
10.3.3.1 Increasing Government Initiatives and Deployment of Digital Pathology Solutions
10.3.4 Denmark
10.3.4.1 High Cancer Prevalence to Boost digital pathology Market Growth in Denmark
10.3.5 Rest of Europe (RoE)
10.3.5.1 Integration & Deployment of Digital Pathology Solutions in France
10.3.5.2 Spain: Implementation of Digital Pathology-Related Projects
10.3.5.3 Digital Pathology Gaining Momentum in the Netherlands
10.4 Asia Pacific
10.4.1 China
10.4.1.1 Industry Initiatives to Boost Digital Pathology Market in China
10.4.1.2 Favorable Initiatives for the Adoption of Telepathology in China
10.4.2 Japan
10.4.2.1 Initiatives By Industry Players for Cancer Diagnosis
10.4.3 India
10.4.3.1 Increasing Incidence of Cancer in India
10.4.4 Rest of Asia Pacific
10.4.4.1 Cancer Control Initiatives in Australia
10.5 RoW
10.5.1.1 Potential for the Growth of Digital Pathology in Africa
10.5.1.2 Increasing Focus of Industry Players on the Middle East
11 Company Profiles (Page No. - 109)
(Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments)*
11.1 Leica Biosystems
11.2 Ventana Medical Systems
11.3 Hamamatsu Photonics
11.4 3DHISTECH
11.5 Koninklijke Philips
11.6 Apollo Enterprise Imaging
11.7 XIFIN
11.8 Huron Digital Pathology
11.9 Visiopharm
11.10 Corista
11.11 Indica Labs
11.12 Objective Pathology Services
*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments Might Not Be Captured in Case of Unlisted Companies.
12 Appendix (Page No. - 145)
12.1 Discussion Guide
12.2 Knowledge Store: Marketsandmarkets Subscription Portal
12.3 Introducing RT: Real-Time Market Intelligence
12.4 Available Customizations
12.5 Related Reports
12.6 Author Details
List of Tables (85 Tables)
Table 1 Global Digital Pathology Market, By Product, 20152022 (USD Million)
Table 2 Digital Pathology Scanners Market, By Country/Region, 20152022 (USD Million)
Table 3 Digital Pathology Scanners Market, By Region, 20152022 (Units)
Table 4 Types of Digital Pathology Software
Table 5 Digital Pathology Software Market, By Country/Region, 20152022 (USD Million)
Table 6 Communication Systems Used in Digital Pathology
Table 7 Digital Pathology Communication Systems Market, By Country/Region, 20152022 (USD Million)
Table 8 Digital Pathology Storage Systems Market, By Country/Region, 20152022 (USD Million)
Table 9 Market, By Type, 20152022 (USD Million)
Table 10 Human Pathology Market, By Country/Region, 20152022 (USD Million)
Table 11 Veterinary Pathology Market, By Country/ Region, 20152022 (USD Million)
Table 12 Global Market Size, By Application, 20152022 (USD Million)
Table 13 Digital Pathology Market for Teleconsultation, By Country/Region, 20152022 (USD Million)
Table 14 Market for Disease Diagnosis, By Country/Region, 20152022 (USD Million)
Table 15 Digital Pathology Market for Drug Discovery, By Country/Region, 20152022 (USD Million)
Table 16 Market for Training and Education, By Country/Region, 20152022 (USD Million)
Table 17 Global Market, By End User, 20152022 (USD Million)
Table 18 Market for Pharmaceutical & Biotechnology Companies, By Country, 20152022 (USD Million)
Table 19 Market for Hospital and Reference Laboratories, By Country, 20152022 (USD Million)
Table 20 Digital Pathology Market for Academic and Research Institutes, By Country, 20152022 (USD Million)
Table 21 Market, By Region, 20152022 (USD Million)
Table 22 North America: Market, By Country, 20152022 (USD Million)
Table 23 North America: Digital Pathology Market, By Product, 20152022 (USD Million)
Table 24 North America: Market, By Type, 20152022 (USD Million)
Table 25 North America: Market, By Application, 20152022 (USD Million)
Table 26 North America: Digital Pathology Market, By End User, 20152022 (USD Million)
Table 27 Conferences/Meetings/Courses/Workshops Held/To Be Held in the US
Table 28 US: Market, By Product, 20152022 (USD Million)
Table 29 US: Market, By Type, 20152022 (USD Million)
Table 30 US: Market, By Application, 20152022 (USD Million)
Table 31 US: Market, By End User, 20152022 (USD Million)
Table 32 Canada: Digital Pathology Market , By Product, 20152022 (USD Million)
Table 33 Canada: Market, By Type, 20152022 (USD Million)
Table 34 Canada: Market, By Application, 20152022 (USD Million)
Table 35 Canada: Digital Pathology Market, By End User, 20152022 (USD Million)
Table 36 Europe: Digital Pathology Market, By Country/Region, 20152022 (USD Million)
Table 37 Europe: Market, By Product, 20152022 (USD Million)
Table 38 Europe: Market, By Type, 20152022 (USD Million)
Table 39 Europe: Market, By Application, 20152022 (USD Million)
Table 40 Europe: Market, By End User, 20152022 (USD Million)
Table 41 UK: Digital Pathology Market , By Product, 20152022 (USD Million)
Table 42 UK: Market, By Type, 20152022 (USD Million)
Table 43 UK: Market, By Application, 20152022 (USD Million)
Table 44 UK: Market, By End User, 20152022 (USD Million)
Table 45 Germany: Digital Pathology Market , By Product, 20152022 (USD Million)
Table 46 Germany: Market, By Type, 20152022 (USD Million)
Table 47 Germany: Market, By Application, 20152022 (USD Million)
Table 48 Germany: Market, By End User, 20152022 (USD Million)
Table 49 Sweden: Market, By Product, 20152022 (USD Million)
Table 50 Sweden: Market, By Type, 20152022 (USD Million)
Table 51 Sweden: Digital Pathology Market , By Application, 20152022 (USD Million)
Table 52 Sweden: Market, By End User, 20152022 (USD Million)
Table 53 Denmark: Digital Pathology Market, By Product, 20152022 (USD Million)
Table 54 Denmark: Digital Pathology Market , By Type, 20152022 (USD Million)
Table 55 Denmark: Market, By Application, 20152022 (USD Million)
Table 56 Denmark: Market, By End User, 20152022 (USD Million)
Table 57 RoE: Market, By Product, 20152022 (USD Million)
Table 58 RoE: Market, By Type, 20152022 (USD Million)
Table 59 RoE: Market, By Application, 20152022 (USD Million)
Table 60 RoE: Market, By End User, 20152022 (USD Million)
Table 61 Asia Pacific: Digital Pathology Market , By Country, 2015-2022 (USD Million)
Table 62 Asia Pacific: Market, By Product, 2015-2022 (USD Million)
Table 63 Asia Pacific: Market, By Type, 2015-2022 (USD Million)
Table 64 Asia Pacific: Market, By Application, 2015-2022 (USD Million)
Table 65 Asia Pacific: Market, By End User, 2015-2022 (USD Million)
Table 66 China: Digital Pathology Market , By Product, 2015-2022 (USD Million)
Table 67 China: Market, By Type, 2015-2022 (USD Million)
Table 68 China: Market, By Application, 2015-2022 (USD Million)
Table 69 China: Market, By End User, 2015-2022 (USD Million)
Table 70 Japan: Digital Pathology Market, By Product, 2015-2022 (USD Million)
Table 71 Japan: Digital Pathology Market, By Type, 2015-2022 (USD Million)
Table 72 Japan: Market, By Application, 2015-2022 (USD Million)
Table 73 Japan: Market, By End User, 2015-2022 (USD Million)
Table 74 India: Market, By Product, 2015-2022 (USD Million)
Table 75 India: Market, By Type, 2015-2022 (USD Million)
Table 76 India: Market, By Application, 2015-2022 (USD Million)
Table 77 India: Market, By End User, 2015-2022 (USD Million)
Table 78 RoAPAC: Market, By Product, 2015-2022 (USD Million)
Table 79 RoAPAC: Market, By Type, 2015-2022 (USD Million)
Table 80 RoAPAC: Market, By Application, 2015-2022 (USD Million)
Table 81 RoAPAC: Market, By End User, 2015-2022 (USD Million)
Table 82 RoW: Market, By Product, 2015-2022 (USD Million)
Table 83 RoW: Market, By Type, 2015-2022 (USD Million)
Table 84 RoW: Market, By Application, 2015-2022 (USD Million)
Table 85 RoW: Market, By End User, 2015-2022 (USD Million)
List of Figures (33 Figures)
Figure 1 Global Digital Pathology Market Segmentation
Figure 2 Global Digital Pathology Market : Research Methodology Steps
Figure 3 Research Design
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Data Triangulation Methodology
Figure 6 Market Analysis, By Product (2017)
Figure 7 Market Analysis, By Type, 2017 vs 2022
Figure 8 Market Analysis, By Application (2017)
Figure 9 Market Analysis, By End User, 2017 vs 2022
Figure 10 Asia Pacific Market to Witness the Highest Growth During the Forecast Period
Figure 11 Increasing Adoption of Digital Pathology is A Major Factor Driving the Growth of the Digital Pathology Market
Figure 12 Teleconsultation is Expected to Account for the Largest Share of the Market in 2017
Figure 13 Human Pathology to Continue to Dominate the Market in 2022
Figure 14 China to Register the Highest CAGR in the Forecast Period
Figure 15 Global Market: Drivers, Restraints, Opportunities, and Challenges
Figure 16 Number of New Cancer Cases, By Country, 2012 vs 2020
Figure 17 Scanners Segment to Dominate the Digital Pathology Products Market During the Forecast Period
Figure 18 Global Market, By Type, 2017 vs 2022 (USD Million)
Figure 19 Teleconsultation Commands for Largest Market Size of the Market in 2017, By Application
Figure 20 Global Market, By End User, 20172022
Figure 21 Global Market, By Region, 2017
Figure 22 North America: Market Snapshot
Figure 23 Increasing Prevalence of Cancer - A Major Factor Driving the North American Market
Figure 24 Europe: Market Snapshot
Figure 25 Europe: Number of Cancer Cases Reported, By Country
Figure 26 Cancer Prevalence in Denmark
Figure 27 Asia Pacific: Market Snapshot
Figure 28 Number of New Cancer Cases, By Type
Figure 29 RoW: Market Snapshot
Figure 30 Danaher Corporation: Company Snapshot
Figure 31 Roche Group: Company Snapshot
Figure 32 Hamamatsu Photonics: Company Snapshot
Figure 33 Koninklijke Philips: Company Snapshot
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Digital Pathology Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Digital Pathology Market